Stonepine Capital Management, LLC

Source: SEC Form 13F · as of Mar 2026

Stonepine Capital Management, LLC holds 41 biotech & pharma companies tracked by BioSniper, totaling $70.1M in value as of Mar 2026 (SEC Form 13F).

Companies held

41

Total value held

$70.1M

CompanySharesValue
ADMAADMA BIOLOGICS, INC.1,890,000$17.0M
CAMPCamp4 Therapeutics Corp1,389,622$6.1M
NKTRNEKTAR THERAPEUTICS85,000$6.1M
TERNTerns Pharmaceuticals, Inc.100,000$5.3M
ZVRAZEVRA THERAPEUTICS, INC.480,000$4.5M
ABEOABEONA THERAPEUTICS INC.846,587$3.8M
ACADACADIA PHARMACEUTICALS INC100,000$2.2M
XOMAXOMA Royalty Corporation69,500$2.2M
HRTXHERON THERAPEUTICS, INC. /DE/2,402,191$1.9M
CTMXCytomX Therapeutics, Inc.400,000$1.9M
XERSXeris Biopharma Holdings, Inc.320,030$1.9M
IKTInhibikase Therapeutics, Inc.957,202$1.6M
CBIOCRESCENT BIOPHARMA, INC.85,000$1.6M
XFORX4 Pharmaceuticals, Inc335,309$1.4M
MNKDMANNKIND CORP516,300$1.3M
SRZNSurrozen Inc.33,005$961K
ARDXARDELYX, INC.150,000$899K
PMVPPMV Pharmaceuticals, Inc.708,102$878K
BIOABioAge Labs, Inc.50,000$875K
MXCTMaxCyte Inc.1,004,673$706K
HELPCYBIN INC.134,060$643K
ZNTLZentalis Pharmaceuticals, Inc.269,100$630K
MSLESatellos Bioscience Inc.100,000$563K
PHATPhathom Pharmaceuticals, Inc.50,010$556K
OKUROnKure Therapeutics, Inc.132,578$549K
VRCAVerrica Pharmaceuticals Inc.99,735$528K
CADLCandel Therapeutics, Inc.102,500$502K
QNRXQuoin Pharmaceuticals, Ltd.53,460$353K
UPBUpstream Bio, Inc.35,000$315K
IRDOpus Genetics, Inc.68,688$313K
ARVNARVINAS, INC.27,500$292K
PLRXPLIANT THERAPEUTICS, INC.224,650$283K
JANXJanux Therapeutics, Inc.20,000$278K
OABIOmniAb Inc.164,045$258K
CGENCOMPUGEN LTD104,300$222K
SABSSAB BIOTHERAPEUTICS, INC.50,000$192K
EDSAEdesa Biotech, Inc.30,000$157K
CABACabaletta Bio, Inc.50,000$135K
KLRSKalaris Therapeutics, Inc.20,400$118K
ELDNEledon Pharmaceuticals, Inc.35,000$108K
OVIDOvid Therapeutics Inc.40,000$89K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Stonepine Capital Management, LLC — Biotech 13F Holdings & Portfolio | BioSniper